HYPERRHO

This brand name is authorized in Hong Kong, Singapore, Turkey, United States

Active ingredients

The drug HYPERRHO contains one active pharmaceutical ingredient (API):

1 Anti-D (rh) immunoglobulin UNII 48W7181FLP - HUMAN RHO(D) IMMUNE GLOBULIN

Human anti-D immunoglobulin contains specific antibodies (IgG) against the Rh(D) antigen of human erythrocytes. It can also contain antibodies to other Rh antigens, e.g. anti-Rh C antibodies. The mechanism by which anti-D immunoglobulin suppresses immunisation to Rh(D) positive red cells is not known. Read about Anti-D (rh) immunoglobulin

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
HYPERRHO S/D FULL DOSE Solution for injection	FDA, National Drug Code (US)	MPI, US: SPL/Old

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
J06BB01	Anti-D (rh) immunoglobulin	J Antiinfectives for systemic use → J06 Immune sera and immunoglobulins → J06B Immunoglobulins → J06BB Specific immunoglobulins
Discover more medicines within J06BB01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: HK	Department of Health Drug Office	Identifier(s): 54494
Country: SG	Health Sciences Authority	Identifier(s): 09660P
Country: TR	İlaç ve Tıbbi Cihaz Kurumu	Identifier(s): 8699769980306
Country: US	FDA, National Drug Code	Identifier(s): 13533-631, 13533-661